|
KDM1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.642200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.289380E-01 |
| Normal-vs-Stage2 |
6.964800E-01 |
| Normal-vs-Stage3 |
4.392200E-02 |
| Normal-vs-Stage4 |
1.298550E-01 |
| Stage1-vs-Stage2 |
7.368400E-01 |
| Stage1-vs-Stage3 |
3.438800E-01 |
| Stage1-vs-Stage4 |
5.987400E-01 |
| Stage2-vs-Stage3 |
4.154200E-01 |
| Stage2-vs-Stage4 |
5.472200E-01 |
| Stage3-vs-Stage4 |
7.988000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.052400E-01 |
| Normal-vs-AfricanAmerican |
7.980000E-04 |
| Normal-vs-Asian |
5.167800E-01 |
| Caucasian-vs-AfricanAmerican |
2.009500E-02 |
| Caucasian-vs-Asian |
4.440800E-01 |
| AfricanAmerican-vs-Asian |
6.666200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.279600E-02 |
| Normal-vs-Female |
8.346000E-02 |
| Male-vs-Female |
9.422000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.715590E-01 |
| Normal-vs-Age(41-60Yrs) |
3.013400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.977800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.656200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.081200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.412800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.471600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.033400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.633570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.231600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.990200E-01 |
| Normal-vs-Grade 2 |
2.958200E-01 |
| Normal-vs-Grade 3 |
1.749950E-01 |
| Normal-vs-Grade 4 |
7.264500E-03 |
| Grade 1-vs-Grade 2 |
9.502400E-01 |
| Grade 1-vs-Grade 3 |
9.687800E-01 |
| Grade 1-vs-Grade 4 |
3.800800E-01 |
| Grade 2-vs-Grade 3 |
7.720200E-01 |
| Grade 2-vs-Grade 4 |
4.418200E-02 |
| Grade 3-vs-Grade 4 |
5.740000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.108800E-01 |
| Normal-vs-ccB subtype |
5.800700E-03 |
| ccA subtype-vs-ccB subtype |
2.155300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.220600E-01 |
| Normal-vs-N1 |
7.198000E-01 |
| N0-vs-N1 |
4.203200E-01 |
|
|
